Development and Use of Human Recombinant <sup>64</sup>Cu-rHCF as a Kidney Glomerulus-Targeted Contrast Agent for Positron Emission Tomography

In this work, we develop recombinant human cationic ferritin (rHCF) as a contrast agent to detect glomeruli in the kidney using positron emission tomography (PET). We first expressed recombinant human ferritin (rHF) in <i>E. coli</i> and then functionalized and radiolabeled it with Copper-64 (<sup>64</sup>Cu) to form <sup>64</sup>Cu-rHCF. Intravenously injected <sup>64</sup>Cu-rHCF bound to kidney glomeruli and was detected by PET. A subchronic toxicity study after an intravenous injection of rHCF revealed no significant toxicity. The development of rHCF is an important step toward the potential clinical translation of CF to detect the nephron number in humans.

Authors

Institutions

Publication Details

Journal
ACS Applied Bio Materials
Published
2024-09-06
DOI
https://doi.org/10.1021/acsabm.4c01027
Citations
1
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and Use of Human Recombinant 64Cu-rHCF as a Kidney Glomerulus-Targeted Contrast Agent for Positron Emission Tomography

Kevin M. Bennett, Edwin J. Baldelomar, Kooresh Isaac Shoghi, David E. Reichert et al.
1 citations
ACS Applied Bio Materials
Radiopharmaceutical Chemistry and Applications
0.40
article

Development and Use of Human Recombinant 64Cu-rHCF as a Kidney Glomerulus-Targeted Contrast Agent for Positron Emission Tomography

Kevin M. Bennett, Edwin J. Baldelomar, Kooresh Isaac Shoghi, David E. Reichert, Daniel L.J. Thorek, Veronica Clavijo Jordan, Hanwen Zhang, Leslie Dawn Wilson, Jennifer R. Charlton, Kasey C. Emoto, Patrick D. Walker
article en
1 citations

Abstract

In this work, we develop recombinant human cationic ferritin (rHCF) as a contrast agent to detect glomeruli in the kidney using positron emission tomography (PET). We first expressed recombinant human ferritin (rHF) in <i>E. coli</i> and then functionalized and radiolabeled it with Copper-64 (<sup>64</sup>Cu) to form <sup>64</sup>Cu-rHCF. Intravenously injected <sup>64</sup>Cu-rHCF bound to kidney glomeruli and was detected by PET. A subchronic toxicity study after an intravenous injection of rHCF revealed no significant toxicity. The development of rHCF is an important step toward the potential clinical translation of CF to detect the nephron number in humans.

ACS Applied Bio MaterialsVol. 7(10)
University of Hawaiʻi at Mānoa (US), Harvard University (US), Washington University in St. Louis (US), Massachusetts General Hospital (US), Arkana Laboratories (US), OPX Biotechnologies (United States) (US), Mallinckrodt (United States) (US), Athinoula A. Martinos Center for Biomedical Imaging (US), University of Virginia (US)
Neurosurgery Research and Education Foundation, Washington University in St. Louis, Institute of Clinical and Translational Sciences, National Institutes of Health, Center for Cellular Imaging, Washington University, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Office of Research Infrastructure Programs, National Institutes of Health
Zero hunger
Openalex Percentile: Top 35%
Radiopharmaceutical Chemistry and Applications
0.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.